An independent guide to cash-pay care. Every price is dated and sourced.

How we check

Foundayo vs Wegovy pill: GLP-1 pills compared

Two GLP-1 pills are FDA-approved for weight loss: the Wegovy pill, oral semaglutide approved Dec 22, 2025 [1], and Foundayo, Lilly's orforglipron approved April 1, 2026 [2]. Both cost $149 to $299 a month on self-pay as of Oct 17, 2026 [3] [4]. The Wegovy pill posted larger average weight loss in its own trial than Foundayo did in a separate trial, while Foundayo can be taken with or without food.

Medical review: pending. A licensed clinician has not yet reviewed this page.

A GLP-1 pill is a once-daily tablet that acts on the GLP-1 receptor to lower appetite and body weight; Foundayo (orforglipron) and the Wegovy pill (semaglutide) are the two approved for chronic weight management.

Wegovy pill result
16.6% vs 2.7% placebo at 64 weeks if people stayed on it; 13.6% counting everyone [1]
Foundayo result
11.1% at 17.2 mg vs 2.1% placebo at 72 weeks [5]
How taken
Wegovy pill: empty stomach, 4 oz water, wait 30 min [6]. Foundayo: with or without food [5]
Price
Both $149 to $299 a month self-pay [3] [4]
Medicare Bridge
Both covered at $50 a month if eligible [7]

The difference in one paragraph

The Wegovy pill is semaglutide, the same molecule as Wegovy and Ozempic shots, in a daily tablet [6]. Foundayo is orforglipron, a different molecule; it is not semaglutide and not tirzepatide [5]. The Wegovy pill has stricter morning rules. Foundayo has more dose steps. Both carry a thyroid C-cell tumor boxed warning [6] [5].

Side-by-side

Foundayo vs Wegovy pill, as of Oct 17, 2026
Wegovy pillFoundayo
DrugSemaglutide tablets (Novo Nordisk) [6]Orforglipron tablets (Eli Lilly) [5]
ApprovedDec 22, 2025 [1]April 1, 2026 [2]
Approved forWeight reduction in adults; heart-risk reduction in adults with heart disease and excess weight [6]Weight reduction and maintenance in adults with obesity, or overweight with a related condition [5]
Dose steps1.5 mg days 1 to 30, 4 mg days 31 to 60, 9 mg days 61 to 90, then 25 mg [6]0.8, 2.5, 5.5 mg at 30-day steps, then 9, 14.5 or 17.2 mg [5]
How to takeMorning, empty stomach, up to 4 oz plain water, wait 30 minutes before food, drinks or other pills [6]Once daily with or without food; swallow whole [5]
Weight trialOASIS 4: 16.6% vs 2.7% at 64 weeks on treatment; 13.6% vs about 2% regardless of adherence [1]Trial 1: 7.4%, 8.3%, 11.1% at 5.5, 9, 17.2 mg vs 2.1% at 72 weeks [5]
Stopped for side effects6.9% vs 5.9% placebo [6]8% overall vs 3% placebo (10% at 17.2 mg) [5]
NauseaSimilar to Wegovy 2.4 mg injection [6]26% to 35% vs 10% placebo [5]
BreastfeedingNot recommended [6]Not recommended [5]
StorageRoom temperature, original bottle [8]Room temperature [9]
Self-pay price$149 (1.5 mg), $199 (4 mg), $299 (9 and 25 mg) [3]$149 (0.8 and 2.5 mg), $199 (5.5 mg), $299 (9 to 17.2 mg) [4]
TrumpRxFrom $149 [10]Not listed on the home page on Oct 17, 2026 [10]
The two drugs were tested in separate trials of different lengths and were not compared head to head.

Which pill works better?

No trial has compared them directly, so there is no clean answer. The Wegovy pill's 13.6% figure counts everyone randomized, whether or not they kept taking it [1]; Foundayo's label reports 11.1% at its top dose over 72 weeks [5]. Those numbers come from different trials and are not directly comparable. Foundayo's label also reports 9.6% at 17.2 mg in adults with type 2 diabetes [5].

If you are comparing pills to shots: in the SURMOUNT-5 trial of the injections, tirzepatide averaged 20.2% and semaglutide 13.7% at 72 weeks [11]. See Wegovy pill vs injection and Wegovy vs Zepbound.

Side effects

Both cause mostly stomach side effects. On Foundayo, nausea ran 26% to 35%, constipation 20% to 27%, diarrhea 21% to 25% and vomiting 13% to 24% across doses, versus 10%, 9%, 11% and 4% on placebo [5]. The Wegovy label says the 25 mg tablet's side effects were similar in type and frequency to the 2.4 mg injection, plus dysesthesia (an altered skin sensation) in 5% versus 0% [6]. FDA required Lilly to run 5 years of enhanced liver-injury monitoring for Foundayo after approval [9]. More on GLP-1 side effects.

Interactions worth knowing

  • Birth control pills: Foundayo's label advises a non-oral or backup method for 30 days after starting and after each dose increase [5].
  • Thyroid medicine: with the Wegovy tablet, levothyroxine exposure rose 33%, so drugs with a narrow dose range may need monitoring [6].
  • Strong CYP3A4 inhibitors: cap Foundayo at 9 mg a day [5].

Foundayo vs Zepbound

Foundayo is not Zepbound. Both are made by Lilly, but Zepbound is tirzepatide, a weekly injection, while Foundayo is orforglipron, a daily pill [12] [5]. Zepbound's SURMOUNT-1 trial averaged 20.9% weight loss at 15 mg [13] versus 11.1% for Foundayo's top dose [5], again from separate trials. Do not take them together: both labels say not to combine with another GLP-1 receptor agonist [12] [5].

Switching from Wegovy to Foundayo

Neither label gives a conversion between the two drugs. Foundayo's label starts everyone at 0.8 mg [5]. The Wegovy label does give a switch between its own forms: start the 25 mg tablet one week after the last 2.4 mg injection [6]. Any switch across brands is set by your prescriber. See switching GLP-1s.

Cost and coverage

Foundayo's 2.5 mg and 5.5 mg prices are temporary through Dec 31, 2026, and its 14.5 and 17.2 mg prices need a refill within 45 days [4]. Commercially insured patients may pay as little as $25 for either [14] [3]. Medicare's GLP-1 Bridge covers Foundayo and Wegovy tablets for a $50 copay from July 1, 2026 through Dec 31, 2027 for eligible Part D members [7] [15]. Prices by dose: Wegovy pill cost and Foundayo.

We may earn a commission if you sign up through some links on this page. It never changes a verdict. How we make money

Programs that prescribe both pills (clean, provisional)

  1. Price
    Zepbound KwikPen $299 (2.5 mg), $399 (5 mg), $449 (7.5 to 15 mg) a month; Wegovy pill $149 to $299; Wegovy pen $199 for the first 2 months at 0.25 to 0.5 mg, then $349, or $399 for 7.2 mg. Membership $39 the first month, then $74 to $149 a month. Checked Oct 17, 2026 [16].
    What you get
    FDA-approved brand drugs only (Zepbound, Wegovy pen and pill, Foundayo, Ozempic). Helps with insurance prior authorizations.
    FDA record
    No FDA warning letter found as of Oct 17, 2026.
    BBB
    BBB profile not checked as of Oct 17, 2026.
    Note
    Membership is billed on top of the drug. The $74 rate needs a 12-month prepay. Verdict: clean (provisional). Ro review

    Visit Ro (Ro Body Program)

  2. LifeMD

    Clean
    Price
    Wegovy pill from $149, Wegovy pen from $199, Zepbound vial from $299 a month, plus a program fee of $39 the first month and $149 a month after. Checked Oct 17, 2026 [17].
    What you get
    Brand GLP-1s with insurance help. Says compounded drugs "may" be prescribed through a compounding partner, with no products or prices shown.
    FDA record
    No FDA warning letter found as of Oct 17, 2026.
    BBB
    BBB profile not checked as of Oct 17, 2026.
    Note
    Its own pages list two different program fees ($149 and $75). Medicare patients are not eligible for the program. Verdict: clean (provisional). LifeMD review

    Visit LifeMD

See Ro prices

Safety

Neither pill is for people with a personal or family history of medullary thyroid carcinoma or MEN 2 [6] [5]. Both are stopped when pregnancy is recognized [6] [5]. Get care for severe stomach pain that will not go away or signs of an allergic reaction, and watch for low blood sugar if you take insulin or a sulfonylurea [6]. Call 911 in an emergency.

Questions people ask

Is Foundayo better than Wegovy?

There is no head-to-head trial. The Wegovy pill averaged 13.6% weight loss at 64 weeks counting everyone (an estimated 16.6% if everyone had stayed on it) [1], and Foundayo averaged 11.1% at its top dose at 72 weeks [5]. Foundayo can be taken with or without food [5].

Is Foundayo semaglutide or tirzepatide?

Neither. Foundayo is orforglipron, a separate GLP-1 receptor agonist made by Eli Lilly and taken as a daily pill [5].

Is Foundayo the same as Zepbound?

No. Zepbound is tirzepatide given as a weekly injection [12]; Foundayo is orforglipron taken as a daily tablet [5]. Both are made by Lilly.

Can you take Zepbound and Foundayo at the same time?

No. Foundayo's label says it is not recommended with another GLP-1 receptor agonist, and Zepbound's label says the same [5] [12].

Are side effects lower with Foundayo than Wegovy?

Not clearly. On Foundayo, nausea ran 26% to 35% and 8% stopped for side effects versus 3% on placebo [5]. On the Wegovy 25 mg tablet, 6.9% stopped versus 5.9% on placebo [6]. These come from different trials.

How much do GLP-1 pills cost?

Self-pay as of Oct 17, 2026: Wegovy pill $149 (1.5 mg), $199 (4 mg) and $299 (9 and 25 mg) [3]; Foundayo $149 (0.8 and 2.5 mg), $199 (5.5 mg) and $299 (9 to 17.2 mg), with the 2.5 and 5.5 mg prices temporary through Dec 31, 2026 [4].

Can you switch from Wegovy to Foundayo?

Yes, with a prescriber. The labels give no conversion between the two, and Foundayo's label starts at 0.8 mg daily [5]. Do not take them together [5].

Sources

17 cited
  1. FDA approves Wegovy pill (press release with OASIS 4 results). Novo Nordisk, Dec 22, 2025.
  2. FDA approves Lilly's Foundayo (orforglipron). Eli Lilly and Company, Apr 1, 2026.
  3. Wegovy self-pay offer. Novo Nordisk (NovoCare), Oct 17, 2026.
  4. Foundayo on LillyDirect: self-pay prices. Eli Lilly and Company (LillyDirect), Oct 17, 2026.
  5. Foundayo (orforglipron) prescribing information. Eli Lilly and Company, Jul 2026.
  6. Wegovy (semaglutide) injection and tablets prescribing information. DailyMed, NLM/NIH, Jun 2026.
  7. Medicare GLP-1 Bridge: information for pharmacies. Centers for Medicare & Medicaid Services, Oct 17, 2026.
  8. Wegovy Medication Guide. DailyMed, NLM/NIH, Jun 2026.
  9. Foundayo NDA 220934 approval letter. US Food and Drug Administration, Apr 1, 2026.
  10. TrumpRx.gov GLP-1 listings. TrumpRx.gov (US government), Oct 17, 2026.
  11. Tirzepatide as compared with semaglutide for the treatment of obesity (SURMOUNT-5). New England Journal of Medicine (PubMed), May 11, 2025.
  12. Zepbound (tirzepatide) prescribing information. DailyMed, NLM/NIH, Aug 2026.
  13. Tirzepatide once weekly for the treatment of obesity (SURMOUNT-1). New England Journal of Medicine (PubMed), Jun 4, 2022.
  14. Foundayo now available (press release). Eli Lilly and Company, Apr 9, 2026.
  15. Weight loss drugs coverage. Medicare.gov (CMS), Oct 17, 2026.
  16. Ro weight loss pricing. Ro, Oct 17, 2026.
  17. LifeMD weight management. LifeMD, Inc., Oct 17, 2026.

This page is general information, not medical advice. Talk with a licensed clinician about your own care.

See Ro pricesWe may earn a commission